Objective: Hepatocellular carcinoma (HCC) is a lethal global disease that requires an
accurate diagnosis. We assessed the potential of 5 serum biomarkers (AFP, AFU, GGT-II …

Background Although a number of serum biomarkers for detection of hepatocellular
carcinoma (HCC) have been explored, their exact diagnostic value remains unclear. We …

Background The clinical value of serum α-fetoprotein (AFP) to detect hepatocellular
carcinoma (HCC) has been questioned due to its low sensitivity and specificity. Other than …

We aimed to determine the surveillance performance of alpha‐fetoprotein (AFP), lectin‐
reactive AFP (AFP‐L3), des‐gamma‐carboxy prothrombin (DCP), and their combinations for …

Current surveillance strategies for hepatocellular carcinoma (HCC) are applied uniformly in
patients with cirrhosis, regardless of their cancer risk. The aim of this study was to compare …

The clinical value of Serum alpha-fetoprotein (AFP) to detect early hepatocellular carcinoma
(HCC) has been questioned due to its low sensitivity and specificity found in recent years …

BACKGROUND: Alpha-fetoprotein (AFP), the only serological marker currently available for
the detection of hepatocellular carcinoma (HCC), is unsatisfactory because of its poor …

Purpose Early detection of hepatocellular carcinoma (HCC) is essential for improved
prognosis and long-term survival. To date, screening for HCC depends on serological …

Objective This study aimed to evaluate the individual and combined diagnostic values of
serum alpha-fetoprotein (AFP), des-gamma-carboxyprothrombin (DCP), glypican-3 (GPC3) …

The role of α-fetoprotein (AFP) in the surveillance and diagnosis of hepatocellular carcinoma
(HCC) has been questioned in recent years due to its low sensitivity and specificity. In …